[EN] SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES [FR] DÉRIVÉS DE BENZOTHIAZOLE SUBSTITUÉS UTILISÉS EN TANT QU'AGONISTES DE GPR40 POUR LE TRAITEMENT DU DIABÈTE DE TYPE II
Disclosed are compositions comprising (a) a GPR40 agonist and (b) an SGLT2 inhibitor, and methods for treating of disorders that are affected by the modulation of the GPR40 receptor and SGLT2 transporter. Such GPR40 compounds are represented by Formula (I) as follows:
wherein ring W, R
1
, R
2
, R
3
, R
5
, R
6
, A, and Z, are defined herein.
Deprotonative C–H Silylation of Functionalized Arenes and Heteroarenes Using Trifluoromethyltrialkylsilane with Fluoride
作者:Midori Sasaki、Yoshinori Kondo
DOI:10.1021/ol503671b
日期:2015.2.20
A highly selective C–H silylation reaction of functionalizedarenes and heteroarenes was developed using Ruppert–Prakash reagent (TMSCF3) activated by alkali metal fluoride. TMSCF3 is considered to play dual roles as a precursor of a mild base and also as a silicon electrophile. The silylation is compatible with sensitive functional groups such as halogen and nitro groups.
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
申请人:Molino F. Bruce
公开号:US20070021408A1
公开(公告)日:2007-01-25
The compounds of the present invention are represented by the following aryl- and heteroaryl-substituted tetrahydrobenzazepine and dihydrobenzazapine derivatives having formulae I(A-E) and formula (II):
where the carbon atom designated * is in the R or S configuration, and the substituents X and R
1
-R
9
are as defined herein.
method for the deprotonative silylation of aromatic C–H bonds has been developed using trifluoromethyltrimethylsilane (CF3SiMe3, Ruppert–Prakash reagent) and a catalytic amount of fluoride. In this reaction, CF3SiMe3 is considered to act as a base and a silicon electrophile. This process is highly tolerant to various functional groups on heteroarenes and benzenes. Furthermore, this method can be applied
ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN
申请人:MOLINO Bruce F.
公开号:US20090118260A1
公开(公告)日:2009-05-07
The compounds of the present invention are represented by the following aryl- and heteroaryl-substituted tetrahydrobenzazepine and dihydrobenzazapine derivatives having formulae I(A-E) and formula (II):
where the carbon atom designated * is in the R or S configuration, and the substituents X and R
1
-R
9
are as defined herein.